analysis er the question 100 00 Ef 4 10

Cornerstones of Cost Management (Cornerstones Series)
4th Edition
ISBN:9781305970663
Author:Don R. Hansen, Maryanne M. Mowen
Publisher:Don R. Hansen, Maryanne M. Mowen
Chapter19: Capital Investment
Section: Chapter Questions
Problem 12E: Refer to Exercise 19.11. 1. Compute the payback period for each project. Assume that the manager of...
icon
Related questions
Question

part \D

8. Cost-benefit & Cost-effectiveness analysis
Given the information below, answer the questions that follow.
Effectiveness
4 life-years gained
10 life-years gained
Current Treatment
New Treatment
Cost
$100,000
$250,000
A. Calculate the ICER for the new treatment, assuming that the new
treatment would replace the old one. Should the new treatment be
adopted? Why?
B. Calculate the cost effectiveness for both current and new treatments.
(Hint: use the ratio of costs over benefits)
Transcribed Image Text:8. Cost-benefit & Cost-effectiveness analysis Given the information below, answer the questions that follow. Effectiveness 4 life-years gained 10 life-years gained Current Treatment New Treatment Cost $100,000 $250,000 A. Calculate the ICER for the new treatment, assuming that the new treatment would replace the old one. Should the new treatment be adopted? Why? B. Calculate the cost effectiveness for both current and new treatments. (Hint: use the ratio of costs over benefits)
C. What is QALY? Briefly explain how QALY might change your answer
to the above questions.
D. Assume that to be fully vaccinated, people (in a given population of
1,000 individuals) need to get three doses of the new and improved
COVID-19 m-RNA vaccines. What is the marginal cost of each dose?
What is the optimal number of doses suggested by the results of the
cost effectiveness analysis?
Using the averted hospitalization.
Using the averted mortality.
Based on your answers above, which is your preferred cost
effectiveness measure? Explain in 1-2 sentences.
(i)
(ii)
Dose of Vaccine Total Cost per
person
0
$400
$450
$460
0
1
2
3
Averted
Hospitalization
0
20,000
10,000
5,000
Averted
Mortality
0
3,000
1,500
200
Transcribed Image Text:C. What is QALY? Briefly explain how QALY might change your answer to the above questions. D. Assume that to be fully vaccinated, people (in a given population of 1,000 individuals) need to get three doses of the new and improved COVID-19 m-RNA vaccines. What is the marginal cost of each dose? What is the optimal number of doses suggested by the results of the cost effectiveness analysis? Using the averted hospitalization. Using the averted mortality. Based on your answers above, which is your preferred cost effectiveness measure? Explain in 1-2 sentences. (i) (ii) Dose of Vaccine Total Cost per person 0 $400 $450 $460 0 1 2 3 Averted Hospitalization 0 20,000 10,000 5,000 Averted Mortality 0 3,000 1,500 200
Expert Solution
steps

Step by step

Solved in 4 steps with 4 images

Blurred answer
Knowledge Booster
Employee Retirement Income Security Act (ERISA)
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Cornerstones of Cost Management (Cornerstones Ser…
Cornerstones of Cost Management (Cornerstones Ser…
Accounting
ISBN:
9781305970663
Author:
Don R. Hansen, Maryanne M. Mowen
Publisher:
Cengage Learning